{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:20:27Z","timestamp":1777515627422,"version":"3.51.4"},"reference-count":31,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Objective: This study aimed to evaluate the association between the Peritoneal Cancer Index (PCI) and the completeness of cytoreductive surgery (CRS) in patients undergoing surgery for advanced ovarian cancer (AOC). Secondary objectives included identifying a PCI cut-off predictive of incomplete cytoreduction, assessing the relationship between PCI and surgical complexity via the Aletti Surgical Complexity Score (SCS), and exploring disease distribution to better understand ovarian cancer distribution. Methods: A retrospective review of 227 patients undergoing primary or interval debulking surgery for AOC from January 2017 to September 2024 at University Hospitals of Derby and Burton was conducted. PCI was recorded intra-operatively, and procedures were classified using the SCS. ROC analysis identified PCI thresholds for incomplete CRS, logistic regression predicted CRS outcomes, and heat mapping visualised disease distribution. Results: Complete CRS of visible disease (R0) was achieved in 90.75% of patients, while 9.25% had incomplete CRS. Median PCI was significantly higher in incomplete CRS cases (28, IQR 21\u201332) compared to complete CRS (15, IQR 8\u201323, p &lt; 0.001). ROC analysis identified a PCI threshold of 25.5 with 71.4% sensitivity and 83.5% specificity for predicting incomplete CRS. PCI &gt; 25.5 increased the odds of incomplete cytoreduction by 12.65 times (p &lt; 0.001). Higher PCI scores correlated with increased surgical complexity, operative time, and blood loss, though complication rates were similar. Heat maps showed stepwise disease distribution from pelvis to upper abdomen. Conclusions: PCI is a reliable predictor of CRS completeness in AOC, with a threshold of &gt;25.5 indicating a high risk of incomplete cytoreduction. The study underscores PCI\u2019s role in surgical planning and calls for multi-centre studies to validate these findings and further examine disease distribution.<\/jats:p>","DOI":"10.3390\/cancers17172790","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:19:32Z","timestamp":1756282772000},"page":"2790","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Peritoneal Cancer Index as a Predictor of Cytoreductive Surgery Outcomes and Heatmapping of Ovarian Cancer Distribution: A Retrospective Analysis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1011-6253","authenticated-orcid":false,"given":"Ayisha A.","family":"Ashmore","sequence":"first","affiliation":[{"name":"Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK"},{"name":"Royal Derby Hospital, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joud","family":"Al-Majali","sequence":"additional","affiliation":[{"name":"Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha Kimi","family":"Chui","sequence":"additional","affiliation":[{"name":"Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Addley","sequence":"additional","affiliation":[{"name":"Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summi","family":"Abdul","sequence":"additional","affiliation":[{"name":"Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viren","family":"Asher","sequence":"additional","affiliation":[{"name":"Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anish","family":"Bali","sequence":"additional","affiliation":[{"name":"Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Phillips","sequence":"additional","affiliation":[{"name":"Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby DE22 3NE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"ref_1","unstructured":"Cancer Research UK. Epithelial Ovarian Cancer (2024, February 14). Epithelial Ovarian Cancer, Available online: https:\/\/www.cancerresearchuk.org\/about-cancer\/ovarian-cancer\/types\/epithelial-ovarian-cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO)","volume":"115","author":"Reuss","year":"2009","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/IGC.0b013e31823de6ae","article-title":"Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: Analysis of the OVCAD data","volume":"22","author":"Polterauer","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Luvero, D., Angioli, R., Notaro, E., Plotti, F., Terranova, C., Angioli, A.M., Festa, A., Stermasi, A., Manco, S., and Diserio, M. (2024). Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery. Diagnostics, 14.","DOI":"10.3390\/diagnostics14222577"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jog.12550","article-title":"Precursors of ovarian cancer in the fallopian tube: Serous tubal intraepithelial carcinoma\u2014An update","volume":"41","author":"Zeppernick","year":"2015","journal-title":"J. Obs. Gynaecol. Res."},{"key":"ref_7","unstructured":"National Disease Registration Service (2023). Ovarian Cancer Audit Feasibility Pilot (OCAFP)\u2014Profile and Treatment Report, NDRS. Available online: https:\/\/digital.nhs.uk\/ndrs\/data\/data-outputs\/cancer-publications-and-tools\/ovarian-cancer-audit-feasibility-pilot-ocafp---profile-and-treatment-report---diagnosis-2015-2019."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","article-title":"Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin","volume":"40","author":"Elias","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","article-title":"A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent","volume":"42","author":"Yonemura","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am. J. Obs. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1072-7515(02)01116-X","article-title":"Achieving RO resection for locally advanced gastric cancer: Is it worth the risk of multiorgan resection?","volume":"194","author":"Martin","year":"2002","journal-title":"J. Am. Coll. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D Graphics Environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"Seaborn: Statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J. Open Source Softw."},{"key":"ref_16","first-page":"51","article-title":"Data Structures for Statistical Computing in Python","volume":"445","author":"McKinney","year":"2010","journal-title":"SciPy"},{"key":"ref_17","first-page":"2825","article-title":"Scikit-Learn: Machine Learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7800-2-3","article-title":"Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer","volume":"2","author":"Harmon","year":"2005","journal-title":"Int. Semin. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/ijgc-2022-004093","article-title":"The peritoneal cancer index as a predictor of complete cytoreduction at primary and interval cytoreductive surgery in advanced ovarian cancer","volume":"33","author":"Fagan","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1245\/s10434-020-08649-6","article-title":"The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer","volume":"28","author":"Lomnytska","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12957-018-1339-0","article-title":"MUAPOS working group (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery) Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index","volume":"16","author":"Llueca","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/1471-0528.15423","article-title":"The NICE classification for \u201cUltra-radical (extensive) surgery for advanced ovarian cancer\u201d guidance does not meaningfully predict postoperative complications: A cohort study","volume":"126","author":"Phillips","year":"2019","journal-title":"BJOG"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.ajog.2009.10.856","article-title":"Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer","volume":"202","author":"Ballester","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"107078","DOI":"10.1016\/j.ejso.2023.107078","article-title":"Neo-adjuvant chemotherapy does not reduce surgical complexity nor the accuracy of intra-operative visual assessment of disease in advanced ovarian cancer","volume":"49","author":"Addley","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Spagnol, G., Bigardi, S., Zorzi, M., Morotti, M., Carollo, M., Bruni, G.M., De Tommasi, O., Tamagnini, M., Xhindoli, L., and Noventa, M. (2024). \u0394-Peritoneal Cancer Index (\u0394-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer. J. Clin. Med., 13.","DOI":"10.2139\/ssrn.4836444"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejso.2020.10.012","article-title":"Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications","volume":"47","author":"Bhatt","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Miceli, V., Gennarini, M., Tomao, F., Cupertino, A., Lombardo, D., Palaia, I., Curti, F., Riccardi, S., Ninkova, R., and Maccioni, F. (2023). Imaging of Peritoneal Carcinomatosis in Advanced Ovarian Cancer: CT, MRI, Radiomic Features and Resectability Criteria. Cancers, 15.","DOI":"10.3390\/cancers15245827"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","article-title":"Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer","volume":"83","author":"Michielsen","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer","volume":"25","author":"Axtell","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Laios, A., Kalampokis, E., Mamalis, M.E., Thangavelu, A., Hutson, R., Broadhead, T., Nugent, D., and De Jong, D. (2023). Exploring the Potential Role of Upper Abdominal Peritonectomy in Advanced Ovarian Cancer Cytoreductive Surgery Using Explainable Artificial Intelligence. Cancers, 15.","DOI":"10.20944\/preprints202310.0564.v1"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2790\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:27Z","timestamp":1760034807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":31,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17172790"],"URL":"https:\/\/doi.org\/10.3390\/cancers17172790","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}